$6.77
-0.79-10.45%
Last update: Nov 11, 6:46 PM
aTyr Pharma Inc
ATYRNASDAQ
aTyr Pharma rose 836.6% from $0.72 to $6.77, ahead of the S&P 500's +11.2%. Its worst day was May 12 (−44.2%), and its low came Oct 27 at $0.12.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.14 beat the $-0.18 estimate on $0.00 revenue (est. $20,000.00).
−8.7% · S&P 500 −1.3%
EPS of $-0.11 beat the $-0.15 estimate on $0.00 revenue (est. $20,000.00).
Story events cover the past 12 months · Times ET
−10.0% · S&P 500 −1.2%
EPS of $-0.11 beat the $-0.12 estimate on $0.00 revenue.
+3.4% · S&P 500 0.0%
aTyr Pharma closed at its lowest level of the year, 82.8% below where the year started.
−19.2% · S&P 500 +0.6%
EPS of $-7.43 missed the $-4.08 estimate on $0.00 revenue.
+5.3% · S&P 500 +0.3%
Where it ended: a close of $6.77 on Nov 11, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $-6.57).
Nothing in the past 12 months.
All ATYR dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ATYR and SPY from Benzinga historical bars. Not investment advice.
